A detailed history of Redhawk Wealth Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Redhawk Wealth Advisors, Inc. holds 9,639 shares of NBIX stock, worth $1.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
9,639
Previous 8,832 9.14%
Holding current value
$1.2 Million
Previous $1.22 Million 8.72%
% of portfolio
0.17%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$114.58 - $153.15 $92,466 - $123,592
807 Added 9.14%
9,639 $1.11 Million
Q2 2024

Jul 16, 2024

SELL
$130.86 - $143.19 $141,328 - $154,645
-1,080 Reduced 10.9%
8,832 $1.22 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $60,375 - $66,551
463 Added 4.9%
9,912 $1.37 Million
Q4 2023

Jan 12, 2024

BUY
$106.07 - $132.76 $1 Million - $1.25 Million
9,449 New
9,449 $1.25 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Redhawk Wealth Advisors, Inc. Portfolio

Follow Redhawk Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.